Emerging fungal diseases: the importance of the host

被引:20
作者
Procop, GW
Roberts, GD
机构
[1] Cleveland Clin Fdn, Clin Microbiol Sect, Cleveland, OH 44195 USA
[2] Mayo Clin, Div Clin Microbiol, Rochester, MN 55905 USA
关键词
D O I
10.1016/j.cll.2004.05.004
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
More yeasts and molds are now recognized to cause more human disease than ever before. This development is not due to a change in the virulence of these fungi, but rather to changes in the human host. These changes include immunosuppression secondary to the pandemic of HIV, the use of life-saving advances in chemotherapy and organ transplantation, and the use of corticosteroids and other immunosuppressive agents to treat a variety of diseases. Fungi that were once considered common saprophytes are now recognized as potential pathogens in these patients. This situation necessitates better communication than ever between the clinician, pathologist, and clinical mycologist to ensure the prompt and accurate determination of the cause of fungal diseases.
引用
收藏
页码:691 / +
页数:31
相关论文
共 256 条
[1]   SYSTEMIC INFECTION BY FUSARIUM IN A BURNED CHILD - EMERGENCE OF A SAPROPHYTIC STRAIN [J].
ABRAMOWSKY, CR ;
QUINN, D ;
CONANT, NF ;
BRADFORD, WD .
JOURNAL OF PEDIATRICS, 1974, 84 (04) :561-564
[2]   AORTIC BYPASS GRAFT INFECTION DUE TO ASPERGILLUS - REPORT OF A CASE AND REVIEW [J].
AGUADO, JM ;
VALLE, R ;
ARJONA, R ;
FERRERES, JC ;
GUTIERREZ, JA .
CLINICAL INFECTIOUS DISEASES, 1992, 14 (04) :916-921
[3]   Antifungal susceptibilities of Paecilomyces species [J].
Aguilar, C ;
Pujol, I ;
Sala, J ;
Guarro, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (07) :1601-1604
[4]   Candiduria in critically ill patients admitted to intensive care medical units [J].
Alvarez-Lerma, F ;
Nolla-Salas, J ;
León, C ;
Palomar, M ;
Jordá, R ;
Carrasco, N ;
Bobillo, F .
INTENSIVE CARE MEDICINE, 2003, 29 (07) :1069-1076
[5]  
Anaissie E, 1992, Curr Top Med Mycol, V4, P231
[6]   THE EMERGING ROLE OF FUSARIUM INFECTIONS IN PATIENTS WITH CANCER [J].
ANAISSIE, E ;
KANTARJIAN, H ;
RO, J ;
HOPFER, R ;
ROLSTON, K ;
FAINSTEIN, V ;
BODEY, G .
MEDICINE, 1988, 67 (02) :77-83
[7]  
ANAISSIE EJ, 1990, NEW YORK STATE J MED, V90, P586
[8]  
ANAISSIE EJ, 1992, J INFECT DIS, V165, P1155, DOI 10.1093/infdis/165.6.1155
[9]   Rejection treatment and cytomegalovirus infection as risk factors for Pneumocystis carinii pneumonia in renal transplant recipients [J].
Arend, SM ;
Westendorp, RGJ ;
Kroon, FP ;
vantWout, JW ;
Vandenbroucke, JP ;
vanEs, LA ;
vanderWoude, FJ .
CLINICAL INFECTIOUS DISEASES, 1996, 22 (06) :920-925
[10]   In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates [J].
Arikan, S ;
Lozano-Chiu, M ;
Paetznick, V ;
Rex, JH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) :327-330